| NTLA Shares Outstanding History Table | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Below is a table of the NTLA shares outstanding history going back to 5/6/2016:
Also see: NTLA Market Cap History NTLA YTD Return |
NTLA Shares Outstanding History — Intellia Therapeutics Share Count Over Time
As of 4/30/2026 Intellia Therapeutics has 139.72 million NTLA shares outstanding. Investors often track the NTLA shares outstanding history to compare shareholder return trends against the change in share count over time.
This page shows NTLA share count trends over time, with 42 historical shares outstanding datapoints presented, dating back to 5/6/2016.
| NTLA Shares Outstanding History Chart | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
NTLA Historical Shares Outstanding: +15.04% CAGR 
Mouse over chart for data details
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| NTLA Stock Price Chart |
| About Intellia Therapeutics Inc |
| Intellia Therapeutics, Inc. is a clinical-stage genome editing company, which is focused on developing curative therapeutics using Clustered, Regularly Interspaced Short Palindromic Repeats/CRISPR associated 9 (CRISPR/Cas9) technology. CRISPR/Cas9 is a technology for genome editing, the process of altering selected sequences of genomic deoxyribonucleic acid. It is focused on leveraging its modular platform to advance in vivo and ex vivo therapies for diseases with high unmet need. We show 42 historical shares outstanding datapoints in our coverage of NTLA's shares outstanding history. Understanding the changing numbers of NTLA shares outstanding — and comprehending the concept of differing number of shares outstanding in general comparing companies like NTLA versus peers — is critical for investors. Many "beginner" or "novice" investors will look at one stock trading at a price of $10 per share and another trading at a price of $20 per share and think the latter company is worth twice as much. Of course, that is a completely meaningless comparison without also knowing how many shares outstanding there are for each of the two companies. Furthermore, via issuance of new shares over time, or the repurchase of existing shares, the number of shares outstanding can fluctuate over the course of history. With this page we aim to empower investors researching NTLA by allowing them to research NTLA shares outstanding history as well as any other stock in our coverage universe. |
| NTLA Current Stock Quote |
Quotes delayed 20 minutes  Free NTLA Email Alerts:
Get Dividend Alerts 
Get SEC Filing Alerts
|
| Video: Shares Outstanding Importance | |
|
Video: Shares Outstanding Importance
| NTLA Share Performance |
| Shares Outstanding Peers |
| Intellia Therapeutics (NTLA) is categorized under the Healthcare sector; to help you further research historical shares outstanding numbers, below are some other companies in the same sector:
NTRA Shares Outstanding History NTRB Shares Outstanding History NTUS Shares Outstanding History NURO Shares Outstanding History NUTX Shares Outstanding History NUVA Shares Outstanding History NUVB Shares Outstanding History NUVL Shares Outstanding History NUWE Shares Outstanding History NVAX Shares Outstanding History More Healthcare companies » |
NTLA Shares Outstanding History | www.SharesOutstandingHistory.com | Copyright © 2017 - 2026, All Rights Reserved
Nothing in SharesOutstandingHistory.com is intended to be investment advice, nor does it represent the opinion of, counsel
from, or recommendations by BNK Invest Inc. or any of its affiliates, subsidiaries or partners.
None of the information contained herein constitutes a recommendation that any particular security, portfolio,
transaction, or investment strategy is suitable for any specific person. All viewers agree that under no
circumstances will BNK Invest, Inc,. its subsidiaries, partners, officers, employees, affiliates, or agents be held
liable for any loss or damage caused by your reliance on information obtained. By visiting, using or viewing this site, you
agree to the following Full Disclaimer & Terms of Use and
Privacy Policy. Video widget and market videos powered by Market News Video. Quote and option data delayed at
least 15 minutes; stock quote data powered by Ticker Technologies, and Mergent.
